دورية أكاديمية

Seroprevalence of SARS-CoV-2 antibodies in Italy in newborn dried blood spots.

التفاصيل البيبلوغرافية
العنوان: Seroprevalence of SARS-CoV-2 antibodies in Italy in newborn dried blood spots.
المؤلفون: Galla, Luisa, Cosma, Chiara, Bertan, Michela, Altinier, Sara, Zaninotto, Martina, Basso, Daniela, Burlina, Alberto, Padoan, Andrea, Plebani, Mario
المصدر: Clinical Chemistry & Laboratory Medicine; 2023, Vol. 61 Issue 2, p311-315, 5p
مصطلحات موضوعية: SARS-CoV-2, IMMUNOGLOBULINS, NEWBORN infants, COVID-19 pandemic, SEROPREVALENCE
مصطلحات جغرافية: ITALY
مستخلص: Serosurveys can be used to monitor COVID-19 seroprevalence and conduct surveillance. Dried blood spot (DBS), used increasingly as a valuable sample to assay severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies (Ab), has several advantages, particularly in infants, due to the limited amount of blood required and its utility in testing a large number of samples in a limited time-frame. We evaluated SARS-CoV-2 IgG Ab prevalence in newborn DBS in the Trentino region of Italy, during the time period January 2020 – December 2021. Anti-SARS-CoV-2 IgG levels were determined in DBS by means of Anti-SARS-CoV-2 QuantiVac IgG ELISA assay (Euroimmun, Lubeck, Germany). Analyses included 2,400 DBS from newborns (54% M, 46% F), samples being collected 2–3 days after birth. The first DBS that tested positive for anti-SARS-CoV-2 IgG antibodies was found in March 2020 and, up to May 2020, only 4 positive results were detected overall. Starting from June 2020, the positivity thresholds increased according to the epidemiological waves of the COVID-19 pandemic in Italy, with a robust increment in the winters of 2020 and 2021. The percentage of positive DBS rose from 0 to 6% to 10–47%, in 2020 and 2021, respectively. This study demonstrates DBS is a suitable tool for both epidemiological purposes and surveillance in the SARS-CoV-2 pandemic, particularly in newborns and pregnant women, saving blood waste and sparing patients any discomfort. [ABSTRACT FROM AUTHOR]
Copyright of Clinical Chemistry & Laboratory Medicine is the property of De Gruyter and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14346621
DOI:10.1515/cclm-2022-0948